Sg Americas Securities, LLC Uro Gen Pharma Ltd. Transaction History
Sg Americas Securities, LLC
- $24.1 Billion
- Q2 2025
A detailed history of Sg Americas Securities, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 1,149,081 shares of URGN stock, worth $22.1 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,149,081
Previous 162,514
607.07%
Holding current value
$22.1 Million
Previous $1.8 Million
776.02%
% of portfolio
0.07%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding URGN
# of Institutions
148Shares Held
44MCall Options Held
146KPut Options Held
42.1K-
Rtw Investments, LP New York, NY4.54MShares$87.2 Million0.96% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$61.3 Million0.08% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$42.2 Million0.27% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$42.1 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY2.15MShares$41.3 Million1.7% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $437M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...